Michael Glikson - EHRA/EAPCI position statement; recommendations and consensus

Posted on 01-06-14

About this lecture

Driving factors and main considerations for the LAA occlusion consensus paper. Also summary of main recommendations, including training & proctoring.

Subjects related to this video

Anatomy Clinical Evidence Indications & Referral LAAO Implantation

Related video's

David Hildick Smith - What’s new: clinical data published and presented since last year

New clinical data for left atrial appendage occlusion therapy, presented & published in 2016. Includes a critical review of the Stroke Prevention section in the 2016 ESC Atrial Fibrillation guidelines.
Clinical Evidence Scientific Meetings

Matthew Price - What’s new: cost effectiveness and health economics

Why might LAA occlusion therapy be cost effective, despite a high procedural cost? This presentation is an overview of the health economics data available for left atrial appendage closure therapy.
Clinical Evidence Scientific Meetings

David Meerkin - What’s new: new devices and new technologies

Review of new left atrial appendage occlusion devices that came to market (CE-mark) or underwent a major redesign in 2016.
LAAO Implantation
To lecture overview